Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank description Gene Value Type Network Comparison Type Interaction Map Filtered green network_comparison red
Results: HTML CSV LaTeX Showing element 2680 to 2729 of 6456 in total 
Value Type: Measured
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Network Comparison Type\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
red\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1340\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transaldolase (ec 2.2.1.2). [source:swissprot;acc:p37837]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6265.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
465.91\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5799.29\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1341\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
abl-interactor 2; abl-interacting protein 1 (sh3-containing protein); abl binding protein 3; arg protein tyrosine kinase-binding protein; abl-interactor protein 2b; similar to spectrin sh3 domain binding protein 1. [source:refseq;acc:nm\_005759]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6269.44\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
465.49\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5803.95\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
alpha-actinin 2 (alpha actinin skeletal muscle isoform 2) (f-actin cross linking protein). [source:swissprot;acc:p35609]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6354.58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07928\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5887.82\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1342\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dual-specificity tyrosine-phosphorylation regulated kinase 1b (ec 2.7.1.-) (mirk protein kinase). [source:swissprot;acc:q9y463]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6354.51\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07926\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5887.86\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
son of sevenless protein homolog 1 (sos-1). [source:swissprot;acc:q07889]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7980.22\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
465.42\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
7514.8\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1343\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dual-specificity tyrosine-phosphorylation regulated kinase 1a (ec 2.7.1.-) (protein kinase minibrain homolog) (mnbh) (hp86) (dual specificity yak1-related kinase). [source:swissprot;acc:q13627]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6354.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07925\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5887.86\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
spectrin sh3 domain binding protein 1; eps8 binding protein; interactor protein ablbp4; abl-interactor protein 1 long; nap1 binding protein. [source:refseq;acc:nm\_005470]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6270.15\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
465.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5804.75\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1344\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
elongation protein 4 homolog; pax6 neighbor gene; chromosome 11 open reading frame 19. [source:refseq;acc:nm\_019040]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6354.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07925\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5887.86\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
mms19-like (met18 homolog, s. cerevisiae); homolog of yeast mms19; mms19 (met18 s. cerevisiae)-like. [source:refseq;acc:nm\_022362]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6825.36\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
465.23\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6360.13\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1345\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
alpha-actinin 1 (alpha-actinin cytoskeletal isoform) (non-muscle alpha-actinin 1) (f-actin cross linking protein). [source:swissprot;acc:p12814]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6354.47\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07925\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5887.88\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nucleolar rna-associated protein alpha isoform. [source:refseq;acc:nm\_022917]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4545.01\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
465.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
4079.81\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1346\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
alpha-actinin 4 (non-muscle alpha-actinin 4) (f-actin cross linking protein). [source:swissprot;acc:o43707]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6354.45\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07924\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5887.89\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sestrin 3. [source:swissprot;acc:p58005]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6120.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
464.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5655.85\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1347\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
presenilins associated rhomboid-like protein. [source:refseq;acc:nm\_018622]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6640.77\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07921\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6153.36\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sestrin 2 (hi95). [source:swissprot;acc:p58004]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6120.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
464.8\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
5655.85\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1348\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytochrome p450 4a11 precursor (ec 1.14.15.3) (cypiva11) (fatty acid omega-hydroxylase) (p-450 hk omega) (lauric acid omega-hydroxylase) (cyp4aii) (p450-hl-omega). [source:swissprot;acc:q02928]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6120.64\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
464.79\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
gamma-butyrobetaine,2-oxoglutarate dioxygenase (ec 1.14.11.1) (gamma-butyrobetaine hydroxylase) (gamma-bbh). [source:swissprot;acc:o75936]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6640.77\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07921\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6153.36\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1349\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytochrome p450 4f3 (ec 1.14.13.30) (cypivf3) (leukotriene-b4 omega- hydroxylase) (leukotriene-b4 20-monooxygenase) (cytochrome p450- ltb-omega). [source:swissprot;acc:q08477]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6120.64\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
464.79\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5655.85\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
potential phospholipid-transporting atpase ih (ec 3.6.3.1) (atpase class i type 11a) (atpase is). [source:swissprot;acc:p98196]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6640.77\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07921\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6153.36\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1350\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytochrome p450 4f8 (ec 1.14.14.1) (cypivf8). [source:swissprot;acc:p98187]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6120.64\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
464.79\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5655.85\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
tetratricopeptide repeat protein 4 (my044 protein). [source:swissprot;acc:o95801]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
7320.39\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0791\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6783.78\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1351\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dual specificity mitogen-activated protein kinase kinase 6 (ec 2.7.1.-) (map kinase kinase 6) (mapkk 6) (mapk/erk kinase 6) (sapkk3). [source:swissprot;acc:p52564]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6587.88\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07906\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6105.23\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
likely ortholog of rat cytochrome p450 4x1. [source:refseq;acc:nm\_178033]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6120.64\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
464.79\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
5655.85\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1352\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytochrome p450 4f12 (ec 1.14.14.1) (cypivf12). [source:swissprot;acc:q9hcs2]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
dual specificity mitogen-activated protein kinase kinase 3 (ec 2.7.1.-) (map kinase kinase 3) (mapkk 3) (mapk/erk kinase 3). [source:swissprot;acc:p46734]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6586.48\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07902\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6104.11\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1353\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cyclin c. [source:swissprot;acc:p24863]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6690.57\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07896\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6200.93\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
cytochrome p450 4f2 (ec 1.14.13.30) (cypivf2) (leukotriene-b4 omega- hydroxylase) (leukotriene-b4 20-monooxygenase) (cytochrome p450- ltb-omega). [source:swissprot;acc:p78329]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6120.64\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
464.79\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5655.85\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1354\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
actin, cytoplasmic 2 (gamma-actin). [source:swissprot;acc:p02571]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6512.64\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07893\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6036.22\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
cytochrome p450 4f11 (ec 1.14.14.1) (cypivf11). [source:swissprot;acc:q9hbi6]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6120.64\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
464.79\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
5655.85\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1355\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dj18d14.4 (cytochrome p450, subfamily iva, polypeptide 11). [source:sptrembl;acc:q9ntl5]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ornithine carbamoyltransferase, mitochondrial precursor (ec 2.1.3.3) (otcase) (ornithine transcarbamylase). [source:swissprot;acc:p00480]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6240.19\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07889\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5783.9\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1356\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
calcipressin 1 (down syndrome critical region protein 1) (myocyte- enriched calcineurin interacting protein 1) (mcip1) (adapt78). [source:swissprot;acc:p53805]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6103.57\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07881\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5657.71\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
cytochrome p450 4b1 (ec 1.14.14.1) (cypivb1) (p450-hp). [source:swissprot;acc:p13584]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6120.64\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
464.79\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5655.85\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1357\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dj947l8.1.6 (novel cub and sushi (scr repeat) domain protein) (fragment). [source:sptrembl;acc:q9h4w2]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6103.54\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0788\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5657.71\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
flotillin-1. [source:swissprot;acc:o75955]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6120.64\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
464.79\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
5655.85\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1358\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
sestrin 1 (p53-regulated protein pa26). [source:swissprot;acc:q9y6p5]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6120.62\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
464.77\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger protein zic 4 (zinc finger protein of the cerebellum 4) (fragment). [source:swissprot;acc:q8n9l1]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6103.54\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.0788\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
5657.71\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1359\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dj947l8.1.1 (novel cub and sushi (scr repeat) domain protein) (fragment). [source:sptrembl;acc:q9h4v7]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
isoleucyl-trna synthetase, cytoplasmic (ec 6.1.1.5) (isoleucine--trna ligase) (ilers) (irs). [source:swissprot;acc:p41252]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6244.56\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
464.73\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5779.83\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1360\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
calcipressin 2 (thyroid hormone-responsive protein zaki-4) (down syndrome candidate region 1-like 1) (myocyte-enriched calcineurin interacting protein 2) (mcip2). [source:swissprot;acc:q14206]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6103.52\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07879\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5657.72\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vesicle-fusing atpase (ec 3.6.4.6) (vesicular-fusion protein nsf) (n- ethylmaleimide sensitive fusion protein) (nem-sensitive fusion protein). [source:swissprot;acc:p46459]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6656.34\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
463.96\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6192.38\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1361\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
calcipressin 3 (down syndrome candidate region 1-like protein 2) (myocyte-enriched calcineurin interacting protein 3) (mcip3). [source:swissprot;acc:q9uka8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6103.52\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07879\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5657.72\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
u2 small nuclear ribonucleoprotein b". [source:swissprot;acc:p08579]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6136.47\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
460.51\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5675.96\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1362\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
deoxyhypusine synthase (ec 2.5.1.46) (dhs). [source:swissprot;acc:p49366]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6606.21\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
459.85\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6146.36\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sequestosome 1; ubiquitin-binding protein p62; phosphotyrosine independent ligand for the lck sh2 domain p62. [source:refseq;acc:nm\_003900]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6820.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.07872\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
6322.75\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1363\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
nonspecific lipid-transfer protein, mitochondrial precursor (nsl-tp) (sterol carrier protein 2) (scp-2) (sterol carrier protein x) (scp-x) (scpx). [source:swissprot;acc:p22307]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
proteasome subunit alpha type 2 (ec 3.4.25.1) (proteasome component c3) (macropain subunit c3) (multicatalytic endopeptidase complex subunit c3). [source:swissprot;acc:p25787]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6803.44\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
459.68\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6343.76\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1364\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna polymerase gamma subunit 1 (ec 2.7.7.7) (mitochondrial dna polymerase catalytic subunit) (polg-alpha). [source:swissprot;acc:p54098]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6145.43\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
459.66\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5685.77\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein c20orf4 (protein cgi-23) (pro0225). [source:swissprot;acc:q9y312]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6272.66\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07868\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5815.14\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1365\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytochrome oxidase biogenesis protein oxa1, mitochondrial precursor (oxa1-like protein) (oxa1hs). [source:swissprot;acc:q15070]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6047.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
458.57\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5589.33\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/